The GCI Dashboard

Version:
Share: whatsapp
Country Rank

179


Suriname

Recovery Rank for 180 countries/regions

Country Rank

182


Suriname

Recovery Rank for 184 countries/regions

COVID-19 Recovery Rating

2

Recovery Index
31.28
(Out of 100)



(100 = Best, 0 = Worst)

COVID-19 Recovery Rating

1

Recovery Index
21.64
(Out of 100)



(100 = Best, 0 = Worst)

COVID-19 Severity Rating

3

Severity Index
48.34
(Out of 100)



(0 = Best, 100 = Worst)

COVID-19 Severity Rating

3

Severity Index
49.93
(Out of 100)



(0 = Best, 100 = Worst)

Stringency Rating

21.74

(100 = Strictest Measures, 0 = No Measures)


Population
581,372

(Low Density)


GNI per capita (US$)

5,210

(Upper middle income)
5 Countries who have made the most progress in
curtailing the spread of the pandemic and can be
used as examples of best practices (Relative Rating)

4
3
2 Countries who are struggling to cope with the crisis
and who may need to consider maintaining stringent
non-pharmaceutical measures (Relative Rating)
1
1 Countries who are coping with the crisis with a low percentage
of infections and resulting deaths per population
(Relative Rating)
2
3 Countries who may be overwhelmed by the crisis with a high
percentage of infections and resulting deaths per population
(Relative Rating)
4
5

Travel Advisory


1. Passengers are not allowed to enter. - This does not apply to: - passengers with an attestation of the Ministry of Foreign Affairs, International Business and International
Cooperation of Suriname obtained before departure by sending an email to [email protected] ; - passengers with a COVID-19 vaccination certificate showing that they were fully vaccinated
at least 2 weeks before arrival. Vaccines accepted are: Abdala, AstraZeneca (Vaxzevria), AZD1222 (SK Bioscience Co Ltd.), Covishield, Janssen, Moderna (Spikevax), Pfizer-BioNTech
(Comirnaty), Sinopharm (BIBP), Sinovac, Soberana 1, Soberana 2, Soberana Plus and Sputnik V. Those vaccinated with Abdala, Soberana 1, Soberana 2, Soberana Plus or Sputnik V must
also have a negative COVID-19 test taken at most 48 hours before departure; - passengers with a COVID-19 recovery certificate and a positive COVID-19 test taken at least 14 days
and at most 3 months before arrival; - passengers younger than 18 years if accompanied by a fully vaccinated parent/guardian.

2. Flights to Suriname are suspended. - This does not apply to flights arriving from Anguilla, Antigua and Barbuda, Aruba, Bahamas, Barbados, Brazil, Cayman Isl., Curacao,
Dominica, French Guiana, Grenada, Guyana, Jamaica, Martinique, Montserrat, Netherlands, Panama, St. Barthelemy, St. Kitts and Nevis, St. Lucia, St. Maarten, St. Martin, St. Vincent
and the Grenadines, Trinidad and Tobago, Turks and Caicos Isl., USA, Virgin Isl. (British) or Virgin Isl. (USA).

3. Passengers arriving from Belgium, Cayman Isl., France, Netherlands, Trinidad and Tobago, United Kingdom or USA with a COVID-19 vaccination certificate showing that they were
fully vaccinated at least 2 weeks before arrival, must have a negative COVID-19 PCR test taken at most 48 hours before departure. Vaccines accepted are: Abdala, AstraZeneca
(Vaxzevria), AZD1222 (SK Bioscience Co Ltd.), Covishield, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm (BIBP), Sinovac, Soberana 1, Soberana 2, Soberana Plus
and Sputnik V. Those vaccinated with Abdala, Soberana 1, Soberana 2, Soberana Plus or Sputnik V must also have a negative COVID-19 test taken at most 48 hours before departure. -
This does not apply to passengers younger than 12 years.

4. Passengers arriving from a country other than Belgium, Cayman Isl., France, Netherlands, Trinidad and Tobago, United Kingdom or USA with a COVID-19 vaccination certificate
showing that they were fully vaccinated at least 2 weeks before arrival, must have: - a negative COVID-19 antigen test taken at most 24 hours before departure; or - a negative
COVID-19 PCR test taken at most 72 hours before departure. Vaccines accepted are: Abdala, AstraZeneca (Vaxzevria), AZD1222 (SK Bioscience Co Ltd.), Covishield, Janssen, Moderna
(Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm (BIBP), Sinovac, Soberana 1, Soberana 2, Soberana Plus and Sputnik V. Those vaccinated with Abdala, Soberana 1, Soberana 2,
Soberana Plus or Sputnik V must also have a negative COVID-19 test taken at most 48 hours before departure. - This does not apply to passengers younger than 12 years.

5. Passengers without a COVID-19 vaccination certificate must have a negative COVID-19 PCR test taken at most 48 hours before arrival. - This does not apply to passengers younger
than 12 years.

6. Passengers must have a confirmed accommodation booking for at least 7 days at a registered SHATA accommodation. - This does not apply to passengers with a COVID-19 vaccination
certificate showing that they were fully vaccinated at least 2 weeks before arrival. Vaccines accepted are: Abdala, AstraZeneca (Vaxzevria), AZD1222 (SK Bioscience Co Ltd.),
Covishield, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm (BIBP), Sinovac, Soberana 1, Soberana 2, Soberana Plus and Sputnik V. Those vaccinated with Abdala,
Soberana 1, Soberana 2, Soberana Plus or Sputnik V must also have a negative COVID-19 test taken at most 48 hours before departure.

7. Passengers must have health insurance to cover COVID-19 expenses. - This does not apply to: - residents of Suriname; - passengers with a COVID-19 vaccination certificate
showing that they were fully vaccinated at least 2 weeks before arrival. Vaccines accepted are: Abdala, AstraZeneca (Vaxzevria), AZD1222 (SK Bioscience Co Ltd.), Covishield,
Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm (BIBP), Sinovac, Soberana 1, Soberana 2, Soberana Plus and Sputnik V. Those vaccinated with Abdala, Soberana 1,
Soberana 2, Soberana Plus or Sputnik V must also have a negative COVID-19 test taken at most 48 hours before departure.

8. Passengers are subject to quarantine for 7 days. - This does not apply to passengers with a COVID-19 vaccination certificate showing that they were fully vaccinated at least 2
weeks before arrival. Vaccines accepted are: Abdala, AstraZeneca (Vaxzevria), AZD1222 (SK Bioscience Co Ltd.), Covishield, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty),
Sinopharm (BIBP), Sinovac, Soberana 1, Soberana 2, Soberana Plus and Sputnik V. Those vaccinated with Abdala, Soberana 1, Soberana 2, Soberana Plus or Sputnik V must also have a
negative COVID-19 test taken at most 48 hours before departure.

9. Passengers arriving from Brazil must have a COVID-19 vaccination certificate showing that they were fully vaccinated at least 2 weeks before arrival. Vaccines accepted are:
Abdala, AstraZeneca (Vaxzevria), AZD1222 (SK Bioscience Co Ltd.), Covishield, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm (BIBP), Sinovac, Soberana 1,
Soberana 2, Soberana Plus and Sputnik V. Those vaccinated with Abdala, Soberana 1, Soberana 2, Soberana Plus or Sputnik V must also have a negative COVID-19 test taken at most 48
hours before departure. - This does not apply to passengers younger than 18 years.

10. Passengers arriving from Brazil must have an attestation of the Ministry of Foreign Affairs, International Business and International Cooperation of Suriname. - This does not
apply to nationals and residents of Suriname.

Travel Advisory information provided and published with permission by IATA. (Timatic COVID-19 Alerts Service has been discontinued on 1/1/2022, please refer this page for latest travel advisory)


Suriname Infection Trend


How can you tell if a curve is really flattening?

The number of daily confirmed cases has been used as an estimation of how severe the COVID-19 situation is in a given country. However, we’ve found that focusing on the country’s cumulative number of active cases gives a clearer picture of whether the infection curve is flattening.


Countries with Similar Characteristics


This table is generated by a GCI-developed tool to match countries based on their similar characteristics such as population, population density, income and climate.

Suriname 21.64 31.28 581,372 Low Density Upper middle income 26-30 deg
Country Recovery Index Recovery Index Population Density GNI per capita Average Temperature
since First Case (Celsius)
Match%
Belize 51.65 58.89 390,353 Low Density Upper middle income 26-30 deg 100%
Guyana 53.11 62.78 782,766 Low Density Upper middle income 26-30 deg 100%
Bhutan 77.84 76.82 763,092 Low Density Lower middle income 11-20 deg 60%
Iceland 58.06 56.65 361,313 Low Density High income < 10 deg 60%

GCI Recovery Forecast


The GCI Recovery Forecasting methodology relies on a Monte Carlo simulation model as we recognise that the factors that contribute to an increase / decrease in confirmed COVID19 cases are highly variable and subject to various localised circumstances and interventions. The P10 / P50 / P90 are probabilities assigned to the forecasts, with P10 being highly optimistic, and P90 being very conservative on recovery and reduction in cases. The forecast model is updated daily based on the latest case data.

Forecast Results:

Situation May Improve. The GCI Model indicates that the situation has a small probability of recovery, but there is insufficient evidence to suggest that the recovery trend will improve significantly in the near future.




Reviewed and Endorsed by:

In Collaboration and
Partnership with:

image

Recognition and Award:

Chairman's Award



Key Sponsor: